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he versatility of stem cells has only recently been
fully recognized. There is evidence that upon adoptive
bone marrow (BM) transplantation (BMT), donor-
derived cells can give rise to neuronal phenotypes in the
brains of recipient mice. Yet only few cells with the charac-
teristic shape of neurons were detected 1–6 mo post-BMT
using transgenic or newborn mutant mice. To evaluate the
potential of BM to generate mature neurons in adult
C57BL/6 mice, we transferred the enhanced green ﬂuorescent
protein (GFP) gene into BM cells using a murine stem cell
virus-based retroviral vector. Stable and high level long-
T
 
term GFP expression was observed in mice transplanted
with the transduced BM. Engraftment of GFP-expressing
cells in the brain was monitored by intravital microscopy.
In a long-term follow up of 15 mo post-BMT, fully devel-
oped Purkinje neurons were found to express GFP in both
cerebellar hemispheres and in all chimeric mice. GFP-
positive Purkinje cells were also detected in BM chimeras
from transgenic mice that ubiquitously express GFP. Based
on morphologic criteria and the expression of glutamic
acid decarboxylase, the newly generated Purkinje cells
were functional.
 
Introduction
 
Several recent studies suggest that adult cell types may cross
the boundaries determined by embryologic trilaminar ori-
gin. Bone marrow (BM)*-derived cells were found to differ-
entiate into skeletal muscle (Ferrari et al., 1998; Gussoni et
al., 1999), cardiomyocytes (Orlic et al., 2001), and epithelial
cells of liver, lung, intestinal tract, and skin (Petersen et al.,
1999; Lagasse et al., 2000; Krause et al., 2001). Stem cells
isolated from skeletal muscle or brain adopted a hematopoi-
etic fate in vivo (Jackson et al., 1999; Bjornson et al., 1999).
In the central nervous system (CNS), which has traditionally
been considered a secluded site, BM-derived cells gave rise to
astrocytes and cells expressing neuronal antigens (Eglitis and
Mezey, 1997; Kopen et al., 1999; Brazelton et al., 2000;
Mezey et al., 2000). At least 0.2% of all cells expressing the
neuronal marker, NeuN, were BM-derived 4 mo after BM
transplantation (BMT). It is at present unclear whether
bone marrow stem cells overcome their intrinsic restrictions
upon exposure to nervous system environment (“transdiffer-
entiation”), or are truly pluripotent stem cells capable of
supplying the adult CNS with neurons and glia. It is also
unclear whether the bone marrow–derived neuronal pheno-
types observed in previous studies persist in the brain after
BMT and develop into functional neurons. Recently, single
hematopoietic stem cells were found to long-term repopu-
late irradiated mice and differentiate into epithelia of various
organs (Krause et al., 2001). In this study, engraftment of
gene-marked BM cells was investigated in the brain up to 15
mo posttransplantation. Single, fully developed cerebellar
Purkinje neurons were found to derive from the donor BM,
underscoring the tremendous differentiative capacity of
adult BM cells.
 
Results and discussion
 
BM cells were transduced with a retroviral vector encoding
green fluorescent protein (GFP) and an antifolate-resistant
dihydrofolate reductase gene. This system permits selection
at the stem cell level to increase the number of gene-modi-
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fied cells after BMT (Allay et al., 1998), which is of particu-
lar relevance for human hematopoietic stem cell transplanta-
tion. GFP is a naturally occurring fluorophore that requires
no substrates or additional gene products for its fluorescence
activity and can thus be scored directly by fluorescence mi-
croscopy (Chalfie, 1995). Transduction efficiency into mu-
rine myeloid clonogenic progenitors averaged 80–90% (
 
n
 
 
 
 
 
7). Retrovirally transduced hematopoietic colonies expressed
high levels of GFP as determined by direct visualization with
phase contrast and fluorescence microscopy (Fig. 1, A and
B). Nontransduced clonogenic progenitors showed no de-
tectable fluorescence (Fig. 1, C and D), indicating the speci-
ficity of GFP as a marker for genetically modified hemato-
poietic cells.
Transplantation of GFP-expressing BM cells into lethally
irradiated mice led to long-term reconstitution of hemato-
poiesis with GFP-marked peripheral blood cell progeny (Fig.
2). All myeloid and lymphocytic lineages displayed a 50–80%
range of GFP labeling, and GFP expression was stable during
the entire observation period of 15 mo posttransplantation.
The sera of BM chimeras were free of replication-competent
retrovirus, which was demonstrated by the failure to transduce
hematopoietic cells. Mice reconstituted with BM cells from
transgenic mice that ubiquitously express GFP displayed
 
 
 
80% GFP marking in peripheral blood mononuclear cells.
Multilineage and long-term repopulation of irradiated hosts
suggests engraftment at the stem cell level.
GFP-positive cells were detected in the brain as early as 2
wk post-BMT. By virtue of their GFP expression, BM-
derived cells could be tracked in the brains of living animals
(Fig. 3 A). Donor-derived cells were located primarily in
perivascular sites, between the basal laminas of endothelia
and astrocytes (Fig. 3, A and B). These cells expressed Iba1,
a marker of monocytes and macrophages (Imai et al., 1996).
Some GFP-expressing cells were found to have left the
perivascular space for the brain parenchyma at 1 mo post-
BMT (Fig. 3 C). By 4 mo after transplantation, the number
of BM-derived cells increased significantly in the brain pa-
renchyma and highest engraftment was observed in the cere-
bellum. All donor-derived cells in cerebellum expressed
monocyte/macrophage-specific antigens, such as F4/80 and
Iba1, up to 4 mo post-BMT (
 
n
 
 
 
  
 
15; unpublished data).
No GFP-marked cells in the cerebellum expressed the astro-
glial marker, glial fibrillary acidic protein (GFAP), or dis-
played a morphology characteristic of neurons and expressed
the neuronal antigen, NeuN. On very rare occasions were
cells detected in the olfactory bulb that coexpressed GFP
and NeuN (Fig. 3, D–F), but none of these cells showed a
morphology characteristic of neurons. However, 12–15 mo
after transplantation, up to 0.1% of fully developed cerebel-
lar neurons were found to express GFP in the perikaryon,
axon, and dendritic tree (Figs. 4, A and B, 5, A, D, and F,
and Table I). No other brain region contained GFP-marked
neurons at this time after transplantation. The GFP-positive
cerebellar neurons were identified as Purkinje cells by their
characteristic morphology, and the expression of calbindin-
D28K (Figs. 4, B–D and 5, A–C), which in the mouse
cerebellum is uniquely expressed in Purkinje neurons
(Nordquist et al., 1988). The cells also contained the 
 
 
 
-ami-
nobutyric acid (GABA)-synthesizing enzyme, glutamic
acid decarboxylase, indicating neurotransmitter synthesis in
Purkinje cells (Fig. 5, E–H; Ottersen and Storm-Mathisen,
Figure 1. Retroviral-mediated transfer of the GFP gene into 
hematopoietic cells. Adult BM cells were transduced with a murine 
stem cell virus–based retroviral vector containing the GFP marker 
gene. Cells were subsequently plated in methylcellulose supple-
mented with hematopoietic growth factors, and analyzed for GFP 
expression after 7 d in culture. The top two panels show identical 
GFP-transduced hematopoietic colonies, visualized separately 
under phase-contrast (A) and fluorescence (B) microscopy. The 
bottom two panels demonstrate nontransduced hematopoietic 
colonies under phase-contrast (C) and fluorescence (D) microscopy. 
Note the lack of background fluorescence in (D).
Figure 2. Reconstitution of hematopoiesis with GFP-marked 
peripheral blood cell progeny in myeloablated mice. Flow cytometric 
analysis of GFP expression was performed in peripheral blood 
leukocytes of lethally irradiated mice 8 mo after transplantation of 
GFP-expressing BM cells (red) and in leukocytes of control mice 
that did not receive GFP-labeled BM (blue). Approximately 70% of 
white blood cells were stably expressing the fluorophore in GFP-BM 
chimeras. All myeloid and lymphocytic populations were labeled, 
but the levels of GFP expression varied within lineages. Highest 
expression was observed in monocytes/macrophages and granulo-
cytes (unpublished data). 
Bone marrow–derived Purkinje cells |
 
 Priller et al. 735
 
1984). They were negative for glial markers, such as Iba1,
GFAP, and S100
 
 
 
. Multiple synaptic contacts (Fig. 4 G)
suggest that the engrafted Purkinje cells are functional. The
differentiation of BM-derived cells into Purkinje cells oc-
curred in both cerebellar hemispheres and in all animals ex-
amined (
 
n
 
 
 
  
 
7). The cell fluorescence resulted from true
expression of the marker gene, as determined by im-
munohistochemistry using an anti-GFP antibody (Fig. 4
E). Immunoelectron microscopic localization of GFP re-
vealed a homogenous cytoplasmic distribution in dendrites
(Fig. 4, F and G), excluding the possibility of GFP uptake
by host Purkinje cells. Although infection of Purkinje cells
by recombinant retrovirus was unlikely given the postmi-
totic character of CNS neurons, and virtually excluded by
the absence of recombinant retrovirus in the blood of chime-
ras, we transplanted BM from transgenic mice that ubiqui-
tously express GFP into lethally irradiated adult mice (
 
n
 
 
 
 
 
2). Thus avoiding retroviral gene transfer, the same differen-
tiation of BM-derived cells into Purkinje cells was observed
at 10–12 mo post-BMT (Fig. 5, A–C and Table I).
This study demonstrates engraftment of Purkinje cells in
adult mice after BM transplantation for the first time. The
data are in line with recent observations suggesting that BM
cells can give rise to cells expressing neuronal antigens in vitro
and in vivo (Kopen et al., 1999; Brazelton et al., 2000; Mezey
et al., 2000; Sanchez-Ramos et al., 2000; Woodbury et al.,
2000). Although the detection of neuronal protein markers
alone could be misleading, the differentiated morphology of
the GFP-expressing Purkinje cells observed in our study sub-
stantiates the capacity of BM-derived cells to generate mature
neurons in the adult CNS. Functional activity of the engrafted
Purkinje neurons is suggested by the presence of neurotrans-
mitter synthesizing enzyme and synaptic junctions. Moreover,
denervated Purkinje cells would show marked changes of den-
dritic arborization (Anderson and Flumerfeldt, 1984).
In contrast to previous findings, our data suggest that neu-
ronal differentiation of BM cells is a rare biological event and
occurs late, after BMT. The observation period in the present
study almost covered the entire life span of a laboratory
mouse. The discrepancy may relate to the fact that we scored
only those GFP-expressing cells as neurons that showed the
characteristic morphology with axon/dendrites and expression
of neuronal antigens. In the regions of adult neurogenesis,
such as the olfactory bulb, engrafted cells underwent apoptosis
before full neuronal differentiation (unpublished data). Inter-
estingly, a recent BMT study in mice using GFP-marked BM
cells revealed that no donor-derived neurons were detectable
in the brain at 6 mo posttransplantation, which is in perfect
agreement with our findings (Nakano et al., 2001). In terms
of macrophage/microglial engraftment and lack of astroglial
differentiation of BM-derived cells, our data are also in line
with recently published results (Brazelton et al., 2000, Na-
kano et al., 2001). With regard to the cerebellum, it remains
enigmatic why engraftment of Purkinje cells was seen at 12
mo, but not at 4 mo post-BMT. Moreover, it is unclear why
BM cells did not contribute to the population of granule cells,
which are the most numerous neurons in the brain. It is
tempting to speculate that late neogenesis of Purkinje cells
represents a physiological response to ageing when almost
30% of the Purkinje cell population, but none of the cerebel-
lar granule cells, are lost (Sturrock, 1990). The decrease in
Purkinje cell number is noticeable in mice at 15 mo, but not
at 6 mo of age. Importantly, recent experimental evidence
suggests that BM stem cells have regenerative capacity (Ferrari
et al., 1998; Lagasse et al., 2000; Orlic et al., 2001).
Purkinje cells are large, GABAergic neurons that serve as
sole output of the cerebellar cortex (Voogd and Glickstein,
1998). Chick–quail chimera work revealed that they arise
from clonally related embryonic founder cells whose progeny
populate each side of the cerebellum, respecting the cerebellar
midline (Alvarez Otero et al., 1993). In this context, it is in-
teresting to note that we found GFP-expressing Purkinje cells
in both cerebellar hemispheres, suggesting that the factors
governing neogenesis of Purkinje cells in the adult may be dif-
Figure 3. Detection of GFP-expressing cells in the brains of BM 
chimeras. 4 wk after transplantation of GFP-expressing BM cells, a 
closed cranial window was implanted in anesthetized mice. After 
intravenous injection of the dye rhodamine B dextran to contrast the 
lumen of cerebral vessels, GFP-expressing cells were detected in 
vivo using laser-scanning microscopy through the cranial window 
(A). Some extraluminal GFP-positive cells extended short cellular 
processes and showed a punctate rhodamine staining from dye 
uptake. These cells were located in the perivascular space (the 
basement membrane is indicated by arrows), as demonstrated by 
immunoelectron microscopy for GFP (B). Note that endothelia (E) 
did not express GFP. In C, a donor-derived cell is visible that has 
crossed the blood brain barrier and is located in the brain parenchyma. 
13 wk post-BMT, a GFP-expressing cell in the olfactory bulb (D) 
demonstrates NeuN-immunoreactivity (arrow in E, immunohis-
tochemistry using Texas red). The overlay of images D and E is 
shown in F. Bars: (A) 5  m; (B and C) 1  m; (D and F) 10  m. 
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ferent from those during cerebellar development. It remains
to be determined which types of BM stem cells give rise to
Purkinje neurons in the adult brain. In the absence of a con-
sensus regarding which markers are consistently expressed on
BM stem cell populations, an analysis of the genomic inser-
tion sites of the retrovirus may in the future help to define the
clonal precursors of BM-derived Purkinje cells. Mesenchymal
stem cells have been shown to generate neurons in vitro and
after intraventricular injection into neonatal mouse brains
(Kopen et al., 1999; Sanchez-Ramos et al., 2000; Woodbury
et al., 2000), but failed to engraft in the brain parenchyma fol-
lowing in utero transplantation (Liechty et al., 2000).
Several technical points need to be addressed. The DNA
content of certain large neurons, notably Purkinje cells, has
been suggested to exceed diploid levels, but a subsequent criti-
cal appraisal of techniques contradicted the findings (Mann et
al., 1978). Hyperdiploid DNA values may represent changes
in chromatin compaction and the presence of single-stranded
DNA related to the metabolic state of Purkinje cells (Bernoc-
chi et al., 1986). Thus, fusion of host Purkinje cells with
GFP-marked blood-borne cells is an unlikely scenario. No
temporal or spatial correlation between the appearance of do-
nor-derived Purkinje cells and the engraftment of macro-
phages in the cerebellum was observed, and GFP-marked
Purkinje cells did not express Iba1 (unpublished data). Al-
though GFP may have promoted the differentiation of BM
cells into neurons, an overwhelming body of evidence suggests
that the fluorophore is biologically inert (Goldman and Roy,
2000). Finally, using transgenic mice that ubiquitously ex-
press GFP, we could exclude the possibility that GFP labeling
of Purkinje cells was a mere result of recombinant retrovirus
taken up by host neurons. The bicistronic vector used in this
study provided high and stable gene expression in hematopoi-
etic cells in the absence of replication-competent retrovirus.
The data suggest that BM cells can, upon adoptive trans-
plantation, generate Purkinje cells in the adult brain. These
findings may have important implications for the therapy of
CNS disorders that are associated with Purkinje cell loss, as
engraftment of BM cells might be enhanced during pathol-
ogy. Interestingly, reduced ataxia and increased life span was
observed in mouse models of Niemann-Pick disease after
transplantation of normal BM, and Purkinje cells were
Figure 4. Characterization of GFP-
expressing Purkinje cells in the brains of 
BM chimeras. 12–15 mo after transplan-
tation of GFP-expressing BM cells, CNS 
engraftment of marrow-derived cells was 
evaluated in brain sections using direct 
fluorescence microscopy. In the cerebel-
lum, single neurons located at the bor-
der of the granular and the molecular 
layer were found to express GFP in the 
perikaryon, axon, and dendrites (A). 
These cells were identified as Purkinje 
neurons by their expression of the 
calcium-binding protein, calbindin-
D28K: section through a GFP-marked 
neuron (B, direct fluorescence 
microscopy) that shows calbindin 
immunoreactivity (arrow in C, 
immunohistochemistry using Texas red). 
The overlay (D) demonstrates that the 
two fluorophores are in the same cell. 
Immunohistochemical staining of 
semithin brain sections using an 
anti-GFP antibody visualized by 
diaminobenzidine revealed GFP immunoreactivity in Purkinje cell dendrites (E, arrow). Nuclei of adjacent granule cells and molecular layer 
interneurons were counterstained with methylene blue. Note that these cells did not show GFP immunoreactivity (E). Cytoplasmic GFP 
expression in Purkinje cell dendrites was demonstrated by immunoelectron microscopy for GFP (F and G). In F, a large GFP-labeled dendrite 
(indicated by arrows) is located in proximity to a blood vessel. Part of this dendrite is shown at higher magnification in G. The cytoplasm of 
the dendrite (D) contains mitochondria (M). Basket fibers terminate on the surface of the dendrite, and axons (Ax) of parallel fibers form asym-
metric synaptic junctions with Purkinje cell dendritic thorns (arrows). Bars: (A–D) 50  m; (E) 10  m; (F) 1  m; (G) 0.25  m.
 
Table I. 
 
Semiquantitative analysis of Purkinje cell engraftment
Mouse GFP labelling
Time
post-BMT GFP
 
 
 
 microglia
GFP
 
 
 
 cells
Perivascular/leptomeningeal
GFP
 
 
 
Purkinje cells
Total
Purkinje cells
 
mo
 
1 Retroviral 12 1,107 2,515 10 13,519
2 Retroviral 12 2,064 2,989 10 13,691
3 Transgenic 10 747 1,331 2 13,110
10–12 mo after transplantation of BM cells expressing GFP under the control of a retroviral or 
 
 
 
-actin promoter, every seventh cerebellar section of the
chimeric mice was analyzed for GFP-expressing cells. Purkinje cells and microglia were identified by their morphology and immunoreactivity for calbindin/
GAD and Iba1, respectively. GFP-positive cells located in perivascular and leptomeningeal sites were also evaluated.  
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present in the cerebellum despite the lack of enzyme activity
in the brain (Miranda et al., 1998).
 
Materials and methods
 
Retroviral transduction of BM cells and transplantation
 
The MGirL22Y murine stem cell virus–based vector was generated by re-
placing the neomycin coding cassette in MSCVNEO2.1 (Hawley et al.,
1994) with an internal ribosomal entry site from the encephalomyocarditis
virus linked to a gene encoding a mutant dihydrofolate reductase (L22Y).
The enhanced GFP gene from EGFP-1 (CLONTECH Laboratories, Inc.) was
cloned into the resulting plasmid upstream of the internal ribosomal entry
site. High-titer, ecotropic MGirL22Y virus–producer cells were generated
by transduction of GP plus E86 cells with MGirL22Y vector particles de-
rived by cotransfection of 293T cells with the plasmid containing the
MGirL22Y sequences and a helper plasmid encoding the required gag,
pol, and env retroviral genes (Persons et al., 1997). The presence of repli-
cation-competent retrovirus from the MGirL22Y virus–producer cells was
ruled out by testing the ability of conditioned medium from the virus pro-
ducer cells to mobilize, in a 
 
mus dunni
 
 test cell line, a recombinant, inte-
grated Moloney leukemia virus (G1Na) which encodes for neomycin phos-
photransferase (McLachlin et al., 1993). Briefly, conditioned media from
the MGirL22Y virus–producer cells was used to infect 
 
mus dunni
 
 cells har-
boring two integrated copies of G1Na (provided by Dr. Vanin, St. Jude’s
Children’s Research Hospital, Memphis, TN). The transduced 
 
mus dunni
 
cells were cultured for 3 wk, and conditioned media was taken from these
cells and tested on naive 
 
mus dunni
 
 cells for the ability to confer neomycin
resistance. No neomycin-resistant colonies were ever detected over multi-
ple independent assays.
BM was harvested from 8–12-wk-old male C57BL/6 mice 2 d after treat-
ment with 150 mg/kg 5-fluoruracil (Sigma-Aldrich). After prestimulation
for 48 h in DME supplemented with 15% heat-inactivated fetal calf serum
(Biochrom), 20 ng/ml murine interleukin-3, 50 ng/ml human interleukin-6
(PromoCell), and 50 ng/ml rat stem cell factor (provided by Amgen). BM
cells were cocultured with irradiated (1,300 cGy) MGirL22Y virus–pro-
ducer cells in the presence of 6 
 
 
 
g/ml polybrene (Sigma-Aldrich). After 48 h,
nonadherent BM cells were rinsed off the producer cell monolayer and
transplanted into lethally irradiated (two doses of 550 cGy separated by 3 h)
adult male C57BL/6 mice. Alternatively, BM was harvested form “green
mice” (Okabe et al., 1997) and transplanted directly into lethally irradiated
adult male C57BL/6 mice. Recipient mice received 5 
 
 
 
 10
 
6
 
 cells by tail
vein injection. For in vitro clonogenic progenitor assays, transduced BM
cells were suspended in 2 ml of methylcellulose supplemented with inter-
leukin-3, interleukin-6, erythropoietin, and stem cell factor (StemCell
Technologies), supporting the growth of myeloid colonies.
 
Flow cytometric analysis of GFP expression in peripheral 
blood cells
 
1, 4, 8, and 12 mo after BMT, peripheral blood obtained by tail vein punc-
ture was examined by fluorescent-activated cell sorting (Becton Dickin-
son). After erylysis, cells labeled with Mac-1-Pe, B220-Pe, Gr-1-Pe
(PharMingen), and CD4-Pe (Becton Dickinson) were analyzed for GFP ex-
pression. Dead cells (propidium iodide–positive) were excluded. Data
were evaluated using the Cellquest
 
TM
 
 software.
 
Immunohistochemical analysis of donor cell engraftment 
in the cerebellum
 
BM chimeric mice (
 
n
 
 
 
 
 
 24) were killed between 2 wk and 15 mo post-
transplantion, and perfused transcardially with 4% paraformaldehyde in
PBS. 30 
 
 
 
m vibratome or 20 
 
 
 
m cryosections were obtained from the
brains. For immunohistochemistry, IgG block was performed and sections
were incubated in PBS supplemented with 5–10% normal goat serum and
0.5% Triton X-100. Primary antibodies were added overnight at dilutions
of 1:200 for anti-calbindin-D28K (mouse monoclonal; provided by Dr.
Veh, Charité, Berlin, Germany), 1:250 for anti–glutamic acid decarbox-
ylase (GAD) (rabbit polyclonal; Chemicon), 1:100 for anti-NeuN (mouse
monoclonal; Chemicon), 1:100 for anti-Iba1 (rabbit polyclonal; provided
by Dr. Imai, National Institute of Neuroscience, Tokyo, Japan), 1:50 for
anti-F4/80 (rat monoclonal; Serotec), 1:2,500 for anti-GFAP (rabbit poly-
clonal; Dako), and 1:100 for anti-S100
 
 
 
 (rabbit polyclonal; provided by
Dr. Veh, Charité, Berlin, Germany). Texas red–conjugated secondary anti-
bodies (goat anti–mouse and goat anti–rabbit; Molecular Probes) were
added at 1:200 for 1 h. Omission of primary antibodies served as negative
control and resulted in no detectable staining. Digital micrographs of GFP
and Texas red fluorescence were obtained on a conventional fluorescence
microscope equipped with a color scanner (Leica) or on a confocal laser
scanning microscope (ZEISS).
 
Quantification of engraftment
 
Semiquantitative analysis of Purkinje cell engraftment was performed in
three representative animals. Every seventh cerebellar section was ana-
lyzed, and the number of GFP-expressing Purkinje cells was determined in
relation to the total number of calbindin- or GAD-stained Purkinje cells in
these sections. Moreover, the remaining GFP-expressing microglia and
macrophages, demonstrating Iba1 immunoreactivity, were counted. In two
representative chimeras (retroviral and transgenic GFP expression), every
single section from the olfactory bulb to the cerebellum was analyzed for
GFP-marked neurons.
 
Ultrastructural analysis of engrafted cells
 
Preembedding immunohistochemistry was performed on 80-
 
 
 
m vi-
bratome sections as described above. A preabsorbed polyclonal anti-GFP
Figure 5. Confocal microscopic 
analysis of BM-derived Purkinje cells. 
12 mo after transplantation of BM cells 
from transgenic mice that ubiquitously 
express GFP, donor-derived Purkinje 
cells were visualized by confocal 
laser–scanning microscopy. The GFP 
fluorescence of an engrafted neuron (A) 
colocalized with calbindin immunore-
activity (B, immunohistochemistry using 
Texas red), characterizing the neuron as 
a Purkinje cell (C, overlay of images A 
and B). GFP-expressing Purkinje cells 
were also detected in chimeric mice 12 
mo after transplantation of BM cells 
transduced with a GFP retroviral vector 
(D, maximum intensity projection of 16 
consecutive scans). Another GFP-
marked neuron is visible in the layer of 
GAD-expressing Purkinje cells (E, overlay 
of the maximum intensity projections of 
GFP and Texas red fluorescence visual-
izing GAD immunoreactivity). The 
single optical section through a GFP-
positive Purkinje cell (F) revealed expression of GAD (G, immunohistochemistry using Texas red) in the Purkinje cell soma as well as in 
GABAergic nerve terminals (F, overlay of images F and G). Bars: (A–D) 25  m; (E) 50  m; (F–H) 25  m. 
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antibody (CLONTECH Laboratories, Inc.) was used at a dilution of 1:250.
Omission of primary antibody served as negative control. Addition of the
secondary biotinylated goat anti–rabbit antibody (Vector Laboratories) was
followed by incubation with the avidin–biotin peroxidase complex (ABC;
Vector Laboratories) and 3,3
 
 
 
-diaminobenzidine/H
 
2
 
O
 
2
 
 (Sigma-Aldrich) ac-
cording to the manufacturer’s instructions. Sections were then fixed in 2%
glutaraldehyde/PBS and immersed in 2% Dalton’s osmium. After dehydra-
tion, the tissue was embedded in araldite. For high resolution light micros-
copy, 1-
 
 
 
m semithin araldite sections were scanned with a Leica color
scanner. Each cell immunoreactive for GFP was sought in adjacent ul-
trathin sections cut on a LKB-ultramicrotome. The sections were mounted
on mesh copper grids and processed for electron microscopy.
 
Intravital microscopy
 
In vivo confocal laser imaging of GFP-expressing cells was performed ac-
cording to a modified protocol of Villringer et al. (1991). Anesthesia was in-
duced in BM chimeric mice by inhalation of 2% halothane in a mixture of
30% O
 
2
 
/70% N
 
2
 
O. Anesthesia was maintained throughout the experiment
by intraperitoneal administration of 750 mg/kg urethane and 150 mg/kg
 
 
 
-chloralose. The femoral artery and vein were cannulated and mean arte-
rial blood pressure was monitored. Systemic arterial pressure was 82 
 
 
 
 8
mm Hg (mean 
 
 
 
 SD; 
 
n
 
 
 
  
 
3). Body temperature was maintained between
36.5
 
 
 
C and 37.5
 
 
 
C using a heating pad. Mice were intubated and ventilated
with a mixture of O
 
2
 
 and air. End tidal CO
 
2
 
 partial pressure was monitored
and kept between 2.5–3.5% by adjusting the respiratory rate, tidal volume,
and inspiration time. After fixation to a stereotaxic frame, a craniotomy was
performed over the parietal cortex. The dura mater was removed and a
closed cranial window was implanted. Mice received 250 mg/kg rhodamine
B dextran (Sigma-Aldrich) by intravenous injection. Subsequently, the brains
were examined for GFP-expressing cells through the coverglass of the cra-
nial window for 3 h using a confocal laser scanning microscope (Leica).
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